The standard dose is 3.2 mg per injection (anchored on 2 mg GHK-Cu with 400 mcg each of BPC-157, TB-4, and KPV)
Its best to use one of the following areas (see Figure 1): Your abdomen (belly), except for the 2-inch (5-centimeter) area around your belly button The middle front or middle outside of your thighs The upper area of your buttocks (butt) The back part of your upper arms, if someone else is giving you the injection If your healthcare provider tells you to use a certain injection site, follow their instructions
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone in vitro and in vivo
This article is for educational purposes only
CagriSema is a two-peptide fixed combination the amylin analogue cagrilintide co-administered with the GLP-1 receptor agonist semaglutide whereas tirzepatide is a single engineered molecule that activates two receptors (GIP and GLP-1) at once
Inspect the injection site to ensure it is clear of bruising, swelling, irritation or hardness